Bill Text: NY A06506 | 2023-2024 | General Assembly | Amended

New York Assembly Bill 6506

Bill Title: Prohibits the sale of xylazine to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

Spectrum: Slight Partisan Bill (Democrat 24-8)

Status: (Engrossed) 2024-03-18 - REFERRED TO CONSUMER PROTECTION [A06506 Detail]

Download: New_York-2023-A06506-Amended.html


                STATE OF NEW YORK
        ________________________________________________________________________

                                         6506--A

                               2023-2024 Regular Sessions

                   IN ASSEMBLY

                                     April 12, 2023
                                       ___________

        Introduced  by  M.  of  A.  TAPIA,  ZACCARO,  ALVAREZ, LAVINE, RAJKUMAR,
          DE LOS SANTOS, SIMONE, REYES, SOLAGES, DICKENS, RIVERA, RAMOS, ARDILA,
          BUTTENSCHON, FORREST, SHIMSKY, LUCAS, CUNNINGHAM, CRUZ, SIMON, SAYEGH,
          EPSTEIN, BICHOTTE HERMELYN, BORES -- read once  and  referred  to  the
          Committee  on Consumer Affairs and Protection -- reported and referred
          to the Committee on  Codes  --  committee  discharged,  bill  amended,
          ordered reprinted as amended and recommitted to said committee

        AN ACT to amend the general business law, in relation to prohibiting the
          sale of xylazine

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. The general business law is amended by adding a new section
     2  392-k to read as follows:
     3    § 392-k. Sale of xylazine. 1. For purposes of this section,  the  term
     4  "xylazine"  shall  mean  a  pharmaceutical drug used for sedation, anes-
     5  thesia, muscle relaxation, and analgesia  in  animals  such  as  horses,
     6  cattle, and other non-human mammals.
     7    2.  No  person,  corporation,  partnership, limited liability company,
     8  firm, online platform, or any other business entity doing business with-
     9  in this state shall sell, offer for sale, or deliver xylazine  to  indi-
    10  viduals without proof of its intended use for institutional, veterinary,
    11  or scientific purposes.
    12    3.  No  person,  corporation,  partnership, limited liability company,
    13  firm, online platform, or other business entity  doing  business  within
    14  this  state  shall sell, offer for sale, or deliver xylazine to individ-
    15  uals under the age of twenty-one.
    16    4. Any person, corporation, partnership,  limited  liability  company,
    17  firm,  online  platform  or  other business entity doing business within
    18  this state which sells, offers for sale, or distributes xylazine,  shall
    19  require  and  retain  sales records, proof of age, and proof of use from
    20  all purchasers.

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD10463-02-3

        A. 6506--A                          2

     1    5. Any person, corporation, partnership,  limited  liability  company,
     2  firm,  online  platform,  or other business entity doing business within
     3  this state that violates the provisions  of  this  section  by  selling,
     4  offering  for  sale, or delivery of xylazine shall be subject to a civil
     5  penalty of not more than five hundred dollars per violation, recoverable
     6  in an action by the attorney general of the state of New York.
     7    § 2. This act shall take effect immediately.